Navigation Links
Clinilabs Welcomes Anesthesiologist Dr. Admir Hadzic Who Will Provide CSF/cCSF Capabilities For Clinilabs

NEW YORK, April 30, 2013 /PRNewswire-iReach/ -- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced the arrival of Dr. Admir Hadzic to the Clinilabs team.  Dr. Hadzic will provide expertise in the development of drugs to treat pain, and also will manage the collection of CSF/cCSF samples in clinical trials.

Dr. Admir Hadzic has been at the forefront of academic anesthesiology for nearly two decades. His work has substantially contributed to the development of functional regional anesthesia anatomy, standardized techniques of nerve blocks, patient outcome benefits of regional anesthesia, and monitoring principles to standardize the practice and decrease the risk of complications of nerve blocks.  He has published numerous peer-reviewed articles and two leading textbooks, and is a founder of the global educational programs Networking World Anesthesia Convention and the New York School of Regional Anesthesia. Through these educational programs, Dr. Hadzic has trained physicians Worldwide in anesthesia techniques and other procedures such as CSF sampling. 

Dr. Gary Zammit , President and CEO of Clinilabs, states "Clinilabs is pleased to welcome Dr. Hadzic to our team.  He is a leader in the field of anesthesia who significantly broadens the capabilities we are able to offer our clients.  We look forward to his consultancy on multicenter pain trials that we manage, as well as his hands-on contribution to the trials being conducted at our NYC and NJ Phase I units that require anesthesia services." 

About Clinilabs Inc.

Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations.  The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide.  Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, metabolic, and Japanese bridging are among our strengths.  Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CROs for specialty projects.  For more information, please visit

Media Contact: Hannah DAoust , Clinilabs, 646-215-6480,

News distributed by PR Newswire iReach:

SOURCE Clinilabs
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. The CNIO welcomes the new academic year with a spotlight on cancer genetics
5. Chiltern Welcomes Cedric Burg And James Gunter
6. Mayo Clinic anesthesiologist earns APSs Walter B. Cannon Award
7. Reproductive health providers should discuss environmental exposure risks with patients
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. Artificial wetlands can provide benefits over the long haul
10. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
11. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
Post Your Comments:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, ... will participate in a fireside chat discussion at the ... New York . The discussion is scheduled for ... .  A replay will be available ... Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications and ...
(Date:11/24/2015)... Nov. 24, 2015 Cepheid (NASDAQ: CPHD ... at the following conference, and invited investors to participate ...      Tuesday, December 1, 2015 at 11.00 a.m. ...      Tuesday, December 1, 2015 at 11.00 a.m. ... New York, NY      Tuesday, December ...
Breaking Biology Technology: